These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29078099)

  • 1. Neuromedin U potentiates ADP- and epinephrine-induced human platelet activation.
    Grippi C; Izzi B; Gianfagna F; Noro F; Falcinelli E; Di Pardo A; Amico E; Donati MB; de Gaetano G; Iacoviello L; Hoylaerts MF; Cerletti C
    Thromb Res; 2017 Nov; 159():100-108. PubMed ID: 29078099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromedin U uses Gαi2 and Gαo to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic β cells.
    Zhang W; Sakoda H; Nakazato Y; Islam MN; Pattou F; Kerr-Conte J; Nakazato M
    PLoS One; 2021; 16(4):e0250232. PubMed ID: 33857254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.
    Wan Y; Zhang J; Fang C; Chen J; Li J; Li J; Wu C; Wang Y
    Peptides; 2018 Mar; 101():69-81. PubMed ID: 29288685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
    Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
    Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and expression patterns of neuromedin U and its receptors in pigs.
    Li X; Niu M; Su J; Ma Z; Jin M; Qiao W; Zhang Y; Feng Y; An N; Hou Y; Yang S; Chuan S; Lei Z
    Neuropeptides; 2017 Aug; 64():47-60. PubMed ID: 28434792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
    Peier A; Kosinski J; Cox-York K; Qian Y; Desai K; Feng Y; Trivedi P; Hastings N; Marsh DJ
    Endocrinology; 2009 Jul; 150(7):3101-9. PubMed ID: 19324999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.
    Zhang Y; Jiang D; Zhang J; Wang F; Jiang X; Tao J
    Cell Signal; 2010 Nov; 22(11):1660-8. PubMed ID: 20599609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.
    Lin TY; Huang WL; Lee WY; Luo CW
    PLoS One; 2015; 10(8):e0136836. PubMed ID: 26317338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor.
    Przygodzka P; Sochacka E; Soboska K; Pacholczyk M; Papiewska-Pająk I; Przygodzki T; Płociński P; Ballet S; De Prins A; Boncela J
    J Exp Clin Cancer Res; 2021 Sep; 40(1):283. PubMed ID: 34493299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromedin U inhibits T-type Ca2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice.
    Wang F; Zhang Y; Jiang X; Zhang Y; Zhang L; Gong S; Liu C; Zhou L; Tao J
    Cell Calcium; 2011 Jan; 49(1):12-22. PubMed ID: 21106238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets.
    Kaczmarek P; Malendowicz LK; Pruszynska-Oszmalek E; Wojciechowicz T; Szczepankiewicz D; Szkudelski T; Nowak KW
    Int J Mol Med; 2006 Nov; 18(5):951-5. PubMed ID: 17016626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does somatostatin confer insulinostatic effects of neuromedin u in the rat pancreas?
    Kaczmarek P; Malendowicz LK; Fabis M; Ziolkowska A; Pruszynska-Oszmalek E; Sassek M; Wojciechowicz T; Szczepankiewicz D; Andralojc K; Szkudelski T; Strowski MZ; Nowak KW
    Pancreas; 2009 Mar; 38(2):208-12. PubMed ID: 18948835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
    Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
    J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromedins NMU and NMS: An Updated Overview of Their Functions.
    Malendowicz LK; Rucinski M
    Front Endocrinol (Lausanne); 2021; 12():713961. PubMed ID: 34276571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMUR1 in the NMU-Mediated Regulation of Bone Remodeling.
    Hsiao YT; Manikowski KJ; Snyder S; Griffin N; Orr AL; Hulsey EQ; Born-Evers G; Zukosky T; Squire ME; Hum JM; Metzger CE; Allen MR; Lowery JW
    Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromedin U inhibits food intake partly by inhibiting gastric emptying.
    Dalbøge LS; Pedersen SL; Secher T; Holst B; Vrang N; Jelsing J
    Peptides; 2015 Jul; 69():56-65. PubMed ID: 25895852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromedin U (NMU) regulates osteoblast differentiation and activity.
    Hsiao YT; Jestes KJ; Jackson KL; Zukosky T; Squire ME; Hum JM; Lowery JW
    Biochem Biophys Res Commun; 2020 Apr; 524(4):890-894. PubMed ID: 32057362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of UBO-QIC as a Gαq inhibitor in platelets.
    Inamdar V; Patel A; Manne BK; Dangelmaier C; Kunapuli SP
    Platelets; 2015; 26(8):771-8. PubMed ID: 25734215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.